Development and Validation of HPLC Methods for the Determination of CYP2D6 and CYP3A4 Activities

Employment of in vitro experimentation to measure the effect of new chemical entities on human cytochrome P450 (CYP) marker activities represents a convenient approach in studying drug metabolism and pharmacokinetics. In this study, simple and accurate high performance liquid chromatograhic (HPLC) methods were developed and validated for quantitative analysis of CYP2D6-mediated dextromethorphan O-demethylation and CYP3A4-mediated testosterone 6 beta-hydroxylation. Both the assays showed a good linearity in the substrate concentration range of 0.05 - 20.0 mu M and 0.01 - 100.0 mu M with limit of detection (LOD) of 0.01 mu M and 0.001 mu M for CYP2D6 and CYP3A4, respectively. The intra- and inter-day precisions were from 7.21% to 12.22% and 3.09% to 14.60% for CYP2D6; and from 4.77% to 9.19% and 3.65% to 11.84% for CYP3A4. Assay accuracy for CYP2D6 ranged from 85.3% to 104.9% over dextrorphan concentrations of 0.05-5.0 mu M; and that of CYP3A4 was 105.1% to 109.6% at hydroxytestosterone concentrations of 0.01-50 mu M. Enzyme kinetic parameters obtained (K-m and V-max) using the two assays were within reported ranges. Thus, the assays were able to serve as activity markers in the assessment of pharmacokinetic drug interaction and metabolism mediated by CYP2D6 and CYP3A4.